Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News
ECHEMI chemical news

Pharma News

Preliminary clinical success of Pfizer's oral GLP-1 agonist

Preliminary clinical success of Pfizer's oral GLP-1 agonist

On September 21, 2022, Pfizer presented the latest clinical data on oral GLP-1 agonists at the EASD2022 meeting.
GLP-1 agonist

2022-09-23

New study shows that daily multivitamins may ameliorate Alzheimer's disease

New study shows that daily multivitamins may ameliorate Alzheimer's disease

September 21st is World Alzheimer's Day. The survey report on the awareness and demand of Alzheimer's disease in China was released recently.
Zebutinib recommended as

Zebutinib recommended as "Class I priority" in international guidelines

The National Comprehensive Cancer Network (NCCN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Guidelines, First Edition 2023, were recently updated.
The Third Domestic Company: Kelun Pharmaceuticals Submits a Listing Application for

The Third Domestic Company: Kelun Pharmaceuticals Submits a Listing Application for "Olaparib"

On September 8, according to CDE's official website, Kelun Pharmaceuticals submitted a marketing application for Olaparib category 4 generic drugs
Kelun Olaparib BRCA CDE

2022-09-09

The IPO of the Largest Domestic Metronidazole API Manufacturer has Passed the Meeting

The IPO of the Largest Domestic Metronidazole API Manufacturer has Passed the Meeting

On the evening of August 26, the announcement of the results of the 57threview meeting of the GEM Listing Committee in 2022 showed that Hubei HongyuanPharmaceutical Technology Co., Ltd.
metronidazole pharma

2022-09-02

The Overall Veterinary Drug API Market was Weak in August, and the Pattern Continued or Difficult to Reverse in September

The Overall Veterinary Drug API Market was Weak in August, and the Pattern Continued or Difficult to Reverse in September

Entering August, the market situation of veterinary drug raw materials changed abruptly, the price stagnation was obvious, the market demand recovery was not as good as expected, the downstream purchases were mainly on-demand
API drug

2022-09-01

The First Capsid Inhibitor: Lenacapavir, a Shining Star in the Field of Anti-AIDS Drugs

The First Capsid Inhibitor: Lenacapavir, a Shining Star in the Field of Anti-AIDS Drugs

Recently, Gilead Sciences announced that its novel HIV antiviral capsid inhibitor Lenacapavir (Sunlenca) received marketing authorization from the European Commission (EC) for the treatment
The Pattern Changes of the Global API Industry and the Analysis of Future Development Trends, What are the Suggestions for the Development of China's APIs?

The Pattern Changes of the Global API Industry and the Analysis of Future Development Trends, What are the Suggestions for the Development of China's APIs?

Over the years, APIs have always occupied the highest proportion in my country's export trade of pharmaceutical products. China's API industry also occupies an important position in the global pharmaceutical industry chain.
API industry

2022-08-30

First BCMA/CD3 dual antibodies approved by EU

First BCMA/CD3 dual antibodies approved by EU

On August 24, Johnson & Johnson/Janssen announced that the European Commission (EC) has granted conditional marketing approval for teclistamab
BCMA

2022-08-29

FDA approves 'ibrutinib' for chronic graft-versus-host disease in children 1 year and older

FDA approves 'ibrutinib' for chronic graft-versus-host disease in children 1 year and older

On August 24, Janssen, a Johnson & Johnson company, announced that the FDA approved the BTK inhibitor ibrutinib (ibrutinib) for the treatment of patients with relapsed/refractory chronic graft-versus-host disease (cGVHD) in children aged 1 year and ol
Can fish oil replace statin lipid-lowering medications?

Can fish oil replace statin lipid-lowering medications?

Many studies on deep-sea fish oil in recent years have found that it does not actually prevent cardiovascular disease. On the one hand, it is because fish oil loses a lot of DHA and EPA during the production process
HMG-CoA statin

2022-08-29

Complaint
Email:
Message:
Send Message